1

2

3

4

5

6

7

8

9

10

11

12

13

14

15

16

17

18

19

20

21

22

23

CDER Nonprescription & Metabolic-Endocrinologic (Joint Meeting)

24

CDER Nonprescription & Pulmonary-Allergy (Joint Meeting)

25

26

27

28

29

30

31

1

2

3

4

5

6

7

8

9

CDER Drug Safety and Risk Management

CBER Cellular, Tissue & Gene Therapies

10

CDER Drug Safety and Risk Management

CBER Cellular, Tissue & Gene Therapies

11

12

13

14

15

16

17

CBER Vaccines and Related Biological Products

18

19

20

21

22

23

24

25

26

27

NCTR Ranch Hands

28

1

2

3

4

5

6

CDER Anti-Infective Drugs

7

CDER Peripheral & Central Nervous System Drugs (Meeting Notice Amended - Change in date, time, and procedure)

8

CDER Peripheral & Central Nervous System Drugs (Meeting Notice Amended - Change in date, time, and procedure)

9

CBER Blood Products

10

CBER Blood Products

11

12

13

CDER Oncologic Drugs (Meeting Notice Amended - Change in date)

14

CDER Oncologic Drugs (Pediatric Subcommittee)

15

16

17

18

19

20

21

22

FDA Pediatric Advisory Committee (Meeting Notice Amended - Change in Time and Agenda)

23

CDER Psychopharmacologic Drugs

24

25

26

27

CDRH Obstetrics and Gynecology Devices

28

CDRH Obstetrics and Gynecology Devices

29

30

31

FDA Science Board

1

2

3

4

5

6

7

8

9

10

11

12

13

14

15

16

17

18

CDER Pharmaceutical Science (Meeting Canceled)

19

CDER Pharmaceutical Science (Meeting Canceled)

20

21

22

23

24

25

CDER Cardiovascular and Renal Drugs

26

CDER Cardiovascular and Renal Drugs

27

28

29

30

1

2

3

4

5

6

7

8

9

10

11

12

13

14

15

16

17

CDER Peripheral and Central Nervous System Drugs

18

CBER Vaccines and Biological Products

19

CBER Vaccines and Biological Products - Research Review SubCommittee

20

21

22

23

CDRH Radiological Devices Panel

24

25

26

27

28

29

30

31

1

2

CDER Oncologic Drugs

CDRH Orthopaedic and Rehabilitation Devices

3

4

5

6

7

8

9

10

11

12

13

14

15

16

17

18

19

20

21

22

23

24

25

26

27

28

29

30

1

2

3

4

5

6

7

8

9

10

11

12

13

CBER Blood Products

14

CBER Blood Products

CDRH Ophthalmic Devices Panel

15

16

17

18

19

20

21

22

23

24

25

26

27

28

29

30

31

1

2

3

4

5

6

7

8

9

10

11

12

13

14

15

16

17

18

19

20

21

22

23

24

CDRH General and Plastic Surgery Devices

25

CDRH General and Plastic Surgery Devices

26

27

28

29

NCTR Science Advisory Board

CDER Reproductive Health Drugs

CDRH Obstetrics and Gynecology Devices

30

NCTR Science Advisory Board

31

1

2

3

4

5

6

CDRH Dental Products Panel

CDER Oncologic Drugs

7

CDRH Dental Products Panel

CDER Oncologic Drugs

NCTR Ranch Hands

CDER Psychopharmacologic Drugs - Meeting Amendment - Cancellation Notice - Meeting Cancelled

8

CDER Psychopharmacologic Drugs - Meeting Amendment 09/08/06 Meeting Cancelled

9

10

11

CDER Anti-Infective Drugs - Meeting Amendment - Sept. 11 date cancelled

12

CDER Anti-Infective Drugs

13

CBER Allergenic Products

14

15

16

17

18

CBER Transmissible Spongiform Encephalopathies - Meeting Amendment
- Meeting Amended

19

CBER Transmissible Spongiform Encephalopathies - Meeting Amendment
- Meeting Amended

CDRH Orthopaedic and Rehabilitation Devices

20

21

CDER Cardiovascular and Renal Drugs

22

23

24

25

CDER Nonprescription Drugs

CVM Veterinary Medicine

26

27

28

CDRH National Mammography Quality Assurance

29

CDRH National Mammography Quality Assurance

30

1

2

3

4

CDER Joint Meeting Endocrinologic & Metabolic Drugs and the Advisory Committee for Pharmaceutical Science

5

CDER Pharmaceutical Science

6

CDER Pharmaceutical Science

7

8

9

10

11

12

13

14

15

16

17

18

CDER Pharmaceutical Science - Clinical Pharmacology Subcommittee

19

CDER Anti-viral Drugs

CDER Pharmaceutical Science - Clinical Pharmacology Subcommittee

20

CDER Anti-viral Drugs

21

22

23

24

25

26

27

28

29

30

31

CDRH Neurological Devices - Meeting Postponement
Meeting Postponed

1

2

3

4

5

6

7

8

9

CDRH Dental Products Panel

10

11

12

13

14

15

16

CDRH Immunology Devices Panel

CBER Vaccines & Related Biological Products

FDA Pediatric Advisory Committee

17

18

19

20

CBER Cellular, Tissue, & Gene Therapies

21

22

23

24

25

26

27

28

29

CDER Arthritis Advisory Committee

30

1

2

3

4

5

6

CDER Pediatric Oncology Subcommittee

CDRH Clinical Chemistry & Clinical Toxicology Devices Panel

7

CDRH Circulatory System Devices Panel

8

CDRH Circulatory System Devices Panel

9

10

11

12

13

CDER Psychopharmacologic Drugs

14

CDER Anti-Infective Drugs and Drug Safety and Risk Management Committees -
NOTE: Meeting Location Changed

CBER Blood Products

15

CDER Anti-Infective Drugs and Drug Safety and Risk Management Committees -
NOTE: Meeting Location Changed

CDRH Medical Devices Dispute Resolution -
NOTE: Meeting Notice Amended (Change in Time)

CBER Transmissible Spongiform Encephalapathies

16

17

18

19

20

21

22

23

24

25

26

27

28

29

30

31